ANNOUNCEMENT

MedCity CONVERGE July 9-10 in Philly gathers payers, providers, medtech, pharma, digital health, policymakers & more.

Topic: Cystic fibrosis

Vertex cystic fibrosis drug succeeds in combo trial

Vertex cystic fibrosis drug succeeds in combo trial

April 18, 2013 4:44 pm by | 0 Comments

April 18 (Reuters) - Vertex Pharmaceuticals Inc said its experimental drug improved lung function in adults with cystic fibrosis in a mid-stage trial, sending its shares up sharply in after-hours ... Read more
An encouraged Savara Pharmaceuticals preps for phase 2 study of inhaled antibiotic for CF patients

An encouraged Savara Pharmaceuticals preps for phase 2 study of inhaled antibiotic for CF patients

March 27, 2013 12:23 pm by | 0 Comments

Friday’s U.S. Food and Drug Administration approval of the TOBI Podhaler was great news for drugmaker Novartis and for the cystic fibrosis community. It was also welcome news for Texas ... Read more
FDA: Rat study shows cystic fibrosis drug Kalydeco may increase risk of cataracts

FDA: Rat study shows cystic fibrosis drug Kalydeco may increase risk of cataracts

August 29, 2012 10:40 am by | 0 Comments

WASHINGTON (Reuters) - U.S. officials warned that children taking Vertex Pharmaceuticals Inc's cystic fibrosis drug may be at risk of getting cataracts, based on a study in juvenile rats.The U.S. ... Read more
Drug developer with phase 3 cystic fibrosis treatment raising $40 million

Drug developer with phase 3 cystic fibrosis treatment raising $40 million

June 14, 2012 9:13 pm by | 0 Comments

A drug developer that recently reported positive phase 3 results for its cystic fibrosis treatment for a severe form of the genetic disorder is raising $40 million in equity, according ... Read more
Four Drugs ’ Each Creating A Tough Dilemma

Four Drugs ’ Each Creating A Tough Dilemma

March 18, 2012 5:34 pm by | 3 Comments

For a parent of a child with cystic fibrosis, a new drug that could eradicate symptoms could be a God send. The same could be said of a parent of ... Read more